Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2026-01-01 @ 9:05 AM
Study NCT ID:
NCT05363358
Status:
COMPLETED
Last Update Posted:
2023-05-01
First Post:
2022-05-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Sponsor:
Takeda
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-27
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-01
Completion Date Type:
ACTUAL
First Submit Date:
2022-05-02
First Submit QC Date:
None
Study First Post Date:
2022-05-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-28
Last Update Post Date:
2023-05-01
Last Update Post Date Type:
ACTUAL